Table 1.
Patient Characteristics and Risk Factors, Tumor Characteristics, and Treatments
| Patient Characteristics, N = 53 Patients (%) | |
|---|---|
| Age at diagnosis | 47.6 (20–68) |
| Smoking | 11 (20%) |
| Diabetes mellitus | 2 (4%) |
| BRCA positive, N = 53 patients | 5 (9%) |
| Tumor characteristics, N = 56 Breasts (%) | |
| Size | 1.6 cm (1 mm to 7 cm) |
| Multifocal | 26 (46%) |
| ER positive | 36 (63%) |
| PR positive | 19 (33%) |
| HER2/Neu positive | 7 (12.5%) |
| Triple negative | 6 (10.5%) |
| Axillary node involvement | 15/53 (28%) |
| Positive FS converted to SSM | 2/53 (3.7%) |
| Treatment, N = 53 (%) | |
| Prior radiation | 6 (11%) |
| Neoadjuvant chemotherapy | 23 (43%) |
| Adjuvant radiation | 23 (43%) |
| Adjuvant chemotherapy | 4 (8%) |
| Antihormonal therapy | 28 (53%) |
| Biologic treatment | 5 (9%) |
BRCA, breast cancer gene; ER, estrogen receptor; HER2/Neu, human epidermal growth factor receptor/Neu; PR, pogesterone receptor.